Injections do not have to pass through the digestive system like oral supplement, and thus the maximum absorption occurs and less time is consumed
Epithalon is not FDA-approved as a pharmaceutical treatment for any indication
Tabata et al., 1999) are illustrative for the pertinence of the poorly resolved problem, illustrative for the diversity of the carriers (i.e., hyaluronate gel carrier (Wang and Aspengberg, 1996), alginate/heparinsacharose microspheres and films (Yu et al., 1998), cellulose gel (Thorn and Aspenberg, 1993), defective form of Pseudomonas exotoxin (Siegall et al., 1994), fibrin adhesive carrier (Walter et al., 1996), biodegredable hydrogen gelatin (Tabata et al., 1999), natural coral, and collagen (Sikiric et al., 2018), there is an inescapable diversity of the carriers and thereby, an evident diversity of the obtained beneficial effects, and disable conclusion
However, its efficacy may vary depending on patient compliance, exercise intensity, and duration, which poses challenges to its widespread implementation
Starting at the lower end and titrating upward is the safest approach